Ocuflox is a fluoroquinolone antibiotic formulated as an ophthalmic solution for topical use. It is employed to treat bacterial infections of the eye such as conjunctivitis and corneal ulcers. The drug works by inhibiting bacterial dna gyrase and topoisomerase iv enzymes. These enzymes are essential for dna replication and transcription in bacteria. Inhibition of their activity disrupts dna synthesis and leads to bacterial cell death. After topical application the medication penetrates the ocular tissues and accumulates within susceptible bacteria to exert its antimicrobial effect.

Ocuflox is an antibacterial eye drop used to treat bacterial eye infections such as conjunctivitis. The active ingredient belongs to a class of fluoroquinolone antibiotics that target bacterial dna replication enzymes. It works by inhibiting bacterial dna gyrase and topoisomerase iv, enzymes essential for copying bacterial dna. This inhibition prevents the bacteria from multiplying and ultimately leads to their death. The drug is applied directly to the eye where it is absorbed into the cornea and conjunctival tissues. By clearing the infection locally the medication restores normal ocular health without systemic exposure.

Ocuflox may cause mild eye irritation in some patients. It can lead to temporary blurred vision after application. Some users report a slight burning sensation during instillation. Allergic reactions such as redness or itching are uncommon but possible. Headache and mild systemic discomfort have been noted in rare cases. These effects are generally transient and resolve without intervention.

Ocuflox may cause mild eye irritation or burning sensation after use. Some users report temporary blurred vision that typically resolves quickly. Allergic reactions such as itching redness or swelling can occur in rare cases. Headache or dizziness have been noted as occasional systemic effects. A bitter taste in the mouth may be experienced shortly after administration. Sensitivity to light or mild photophobia can develop during treatment. Dryness of the ocular surface is another infrequent side effect reported.